Our San Diego location hosts the following teams - Laboratory Operations, Facilities, Technology, TOCR, Research and Development (Early Research and Assay Development), Medical, and Legal teams. Client Services and other teams will be there as well soon.
In June of 2020, we completed the acquisition of Lexent Bio, Inc., a precision oncology company located in California, developing novel multiomics liquid biopsy platforms to advance cancer care. This acquisition will accelerate our research and development strategy and expand its existing liquid biopsy platforms to advance cancer care for patients. The technology developed by Lexent Bio complements our existing efforts and partnerships aimed at developing advanced diagnostics for physicians, as well as genomically evaluating disease progression and informing treatment decisions at earlier stages of disease. Read more HERE.